(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide

C73H67F4N23O5 — CID 158765100

IUPAC(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide
SMILESCc1cc(-c2ncn(/C=C(/C(N)=O)c3c(C)noc3C)n2)cc(C(F)(F)F)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccc4cn[nH]c4c3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cccnc3F)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc(N)nc3)n2)c1
InChIInChI=1S/C20H18N6O.C18H16F3N5O2.C18H16FN5O.C17H17N7O/c1-12-5-13(2)7-16(6-12)20-22-11-26(25-20)10-17(19(21)27)14-3-4-15-9-23-24-18(15)8-14;1-9-4-12(6-13(5-9)18(19,20)21)17-23-8-26(24-17)7-14(16(22)27)15-10(2)25-28-11(15)3;1-11-6-12(2)8-13(7-11)18-22-10-24(23-18)9-15(17(20)25)14-4-3-5-21-16(14)19;1-10-3-11(2)5-12(4-10)16-22-9-24(23-16)8-14(15(18)25)13-6-20-17(19)21-7-13/h3-11H,1-2H3,(H2,21,27)(H,23,24);4-8H,1-3H3,(H2,22,27);3-10H,1-2H3,(H2,20,25);3-9H,1-2H3,(H2,18,25)(H2,19,20,21)/b17-10+;14-7+;15-9+;14-8+
InChIKeyIPDSQAHIMOIOPX-YPPVMSHQSA-N
MW1422.49 g/mol
LogP10.28
Rot. Bonds16

About (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide

(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide (PubChem CID 158765100) has the molecular formula C73H67F4N23O5 and a molecular weight of 1422.49 g/mol. Its IUPAC name is (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide.

Molecular Properties

Compound Name(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide
PubChem CID158765100
Molecular FormulaC73H67F4N23O5
Molecular Weight1422.49 g/mol
Exact Mass1421.56
IUPAC Name(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide
SMILESCc1cc(-c2ncn(/C=C(/C(N)=O)c3c(C)noc3C)n2)cc(C(F)(F)F)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccc4cn[nH]c4c3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cccnc3F)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc(N)nc3)n2)c1
InChIInChI=1S/C20H18N6O.C18H16F3N5O2.C18H16FN5O.C17H17N7O/c1-12-5-13(2)7-16(6-12)20-22-11-26(25-20)10-17(19(21)27)14-3-4-15-9-23-24-18(15)8-14;1-9-4-12(6-13(5-9)18(19,20)21)17-23-8-26(24-17)7-14(16(22)27)15-10(2)25-28-11(15)3;1-11-6-12(2)8-13(7-11)18-22-10-24(23-18)9-15(17(20)25)14-4-3-5-21-16(14)19;1-10-3-11(2)5-12(4-10)16-22-9-24(23-16)8-14(15(18)25)13-6-20-17(19)21-7-13/h3-11H,1-2H3,(H2,21,27)(H,23,24);4-8H,1-3H3,(H2,22,27);3-10H,1-2H3,(H2,20,25);3-9H,1-2H3,(H2,18,25)(H2,19,20,21)/b17-10+;14-7+;15-9+;14-8+
InChIKeyIPDSQAHIMOIOPX-YPPVMSHQSA-N
XLogP10.28
TPSA414.60 Ų
H-Bond Donors6
H-Bond Acceptors23
Rotatable Bonds16
Heavy Atoms105
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001422.49
LogP ≤ 510.28
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide?
The IUPAC name of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide (CID 158765100) is (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide.
What is the SMILES notation for (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide?
The canonical SMILES for (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide is Cc1cc(-c2ncn(/C=C(/C(N)=O)c3c(C)noc3C)n2)cc(C(F)(F)F)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccc4cn[nH]c4c3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cccnc3F)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc(N)nc3)n2)c1.
What is the InChIKey of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide?
The InChIKey is IPDSQAHIMOIOPX-YPPVMSHQSA-N. The full InChI is InChI=1S/C20H18N6O.C18H16F3N5O2.C18H16FN5O.C17H17N7O/c1-12-5-13(2)7-16(6-12)20-22-11-26(25-20)10-17(19(21)27)14-3-4-15-9-23-24-18(15)8-14;1-9-4-12(6-13(5-9)18(19,20)21)17-23-8-26(24-17)7-14(16(22)27)15-10(2)25-28-11(15)3;1-11-6-12(2)8-13(7-11)18-22-10-24(23-18)9-15(17(20)25)14-4-3-5-21-16(14)19;1-10-3-11(2)5-12(4-10)16-22-9-24(23-16)8-14(15(18)25)13-6-20-17(19)21-7-13/h3-11H,1-2H3,(H2,21,27)(H,23,24);4-8H,1-3H3,(H2,22,27);3-10H,1-2H3,(H2,20,25);3-9H,1-2H3,(H2,18,25)(H2,19,20,21)/b17-10+;14-7+;15-9+;14-8+.
What are the key properties of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide?
(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide has a molecular weight of 1422.49 g/mol, XLogP of 10.28, 16 rotatable bonds, 6 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(1H-indazol-6-yl)prop-2-enamide is sourced from PubChem (CID 158765100), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).